Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Research & Development In Brief

This article was originally published in The Tan Sheet

Executive Summary

Cancer survivors' CAM use: Slightly more than 40 percent of adult cancer survivors use nutritional supplements and vitamins as a complement to conventional treatment, according to a study of complementary treatment methods published online Aug. 4 in the journal Cancer. Affluent, well-educated Hispanics and "other" racial groups are more likely to take vitamins and supplements, as are women and breast and ovarian cancer survivors, according to the longitudinal, nationwide study for the American Cancer Society which surveyed 5,901 adult cancer survivors. The complementary method most frequently reported of the 19 included in the survey was prayer/spiritual practice (61.4 percent), while relaxation as treatment was reported by 44.3 percent and faith/spiritual healing by 42.4 percent, say the researchers led by Ted Gansler, a physician and member of the ACS staff

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102033

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel